InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-12-23 00:00:00 ET · period of report 2022-12-01 · accession 0001209191-22-062657 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-12-23 2022-12-01+ CPIX Young Caroline Dir P - Purchase $2.24 +379 19.2K +2% +$848.69

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-05 P A 20 $2.19 19,268 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
2 Common Common Stock 2022-12-06 P A 20 $2.19 19,288 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
3 Common Common Stock 2022-12-07 P A 20 $2.18 19,308 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
4 Common Common Stock 2022-12-08 P A 20 $2.19 19,328 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
5 Common Common Stock 2022-12-09 P A 20 $2.15 19,348 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
6 Common Common Stock 2022-12-12 P A 20 $2.14 19,368 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
7 Common Common Stock 2022-12-13 P A 20 $2.18 19,388 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
8 Common Common Stock 2022-12-14 P A 20 $2.21 19,408 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
9 Common Common Stock 2022-12-15 P A 20 $2.24 19,428 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
10 Common Common Stock 2022-12-16 P A 20 $2.22 19,448 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
11 Common Common Stock 2022-12-19 P A 30 $2.21 19,478 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
12 Common Common Stock 2022-12-20 P A 109 $2.31 19,587 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
13 Common Common Stock 2022-12-01 P A 20 $2.33 19,228 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
14 Common Common Stock 2022-12-02 P A 20 $2.31 19,248 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.